You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MBRX Award Disclosure
Foster Jonathan P. · SEC Form 4 · Filed Oct 16, 2026
Award
Reported value range
Not reported
Foster Jonathan P. Chief Financial Officer
MBRX
Transaction date
Oct 15, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 1 day later
MBRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 260,000 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001437749-26-032864
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$11.28K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moleculin Biotech, Inc. MBRX | Award | Oct 15, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX | Exercise | Oct 15, 2026 | $0 |
| Moleculin Biotech, Inc. MBRX | Disposition | Oct 15, 2026 | $11.28K |
| Moleculin Biotech, Inc. MBRX Current | Award | Oct 15, 2026 | Not reported |
| Moleculin Biotech, Inc. MBRX | Exercise | Oct 15, 2026 | Not reported |